Matus George Michael

Red Cat CTO Matus George Michael sold 381,584 shares for $5,287,518.51 across 3 transactions, reducing stake by 55.6%

Matus George Michael, Red Cat's CTO, executed 3 separate sales totaling 381,584 shares for $5,287,518.51 between December 18–26, 2024, at prices ranging from $12.10 to $14.67 (blended average $13.86), reducing his holdings from 685,990 to 304,406 shares (55.6% reduction). This follows a dramatic 378.9% gain over 90 days and a 32.2% surge over 30 days, coinciding with the stock recovering from a 52-week low of $0.58 toward $13.41. The company remains unprofitable (net income -$13.3M on latest-quarter revenue of $1.5M), though full-year revenue grew 80.0%. His rapid series of liquidation sales near the 52-week high, combined with the company's ongoing cash-burn profile and absence of profitability, warrants investor scrutiny regarding the CTO's confidence in near-term prospects.

CTO Matus George Michael sold 287,113 shares of RCAT at $9.94 on 2024-12-20 (total $2,853,903.22), reducing holdings 29.5% post-transaction.

Matus George Michael, serving as CTO, executed a substantial open-market sale of 287,113 shares worth $2,853,903.22 near the stock's recent highs, reducing his stake from 973,103 shares to 685,990 shares. The sale occurred when RCAT was trading at $9.94, within 6.3% of its 52-week high of $11.77, and followed a 325.9% rally over 90 days and +23.0% gain over the prior 30 days. The company is unprofitable, with net income of $-13,334,618.00 against quarterly revenue of $1,534,727.00, despite reporting 80.0% annual revenue growth. This sizable reduction of a C-level executive's shareholding during a period of elevated valuation and after substantial price appreciation warrants investor attention, particularly given the company's ongoing losses despite revenue expansion.

RCAT CTO Matus George Michael sold 112,686 shares at $9.20 (12/18/24); holds 973,103 post-sale

CTO Matus George Michael executed a discretionary open-market sale of 112,686 shares on 2024-12-18 at $9.20 per share, reducing his holdings by 112,686 shares (-10.4% vs pre-transaction holdings of 1,085,789 shares). The sale occurred in a stock that has appreciated substantially on a 30-day basis (+68.8%) and 90-day basis (+243.4%), though it trades 8.7% below its 52-week high of $11.77. The company posted latest-quarter revenue of $1,534,727.00 against a net loss of $-13,334,618.00, highlighting a significant earnings drain despite annual revenue growth of +80.0% year-over-year. This sale by the chief technology officer—a C-suite executive—during a period of marked stock appreciation and against the backdrop of substantial ongoing losses warrants investor attention to whether fundamental operational challenges are factoring into executive dispositions.